戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 .9%) than true infarction as demonstrated by triphenyltetrazolium chloride (TTC) (24.6+/-1.4%, P<0.00
2  weeks), the lesion was assessed using 2,3,5-triphenyltetrazolium chloride (TTC) or hematoxylin and e
3                   Necrosis was assessed with triphenyltetrazolium chloride (TTC) staining and a trans
4 ) and to compare 99mTc-sestamibi imaging and triphenyltetrazolium chloride (TTC) staining for reliabi
5 ly to the rat, and often paired with 2, 3, 5-triphenyltetrazolium chloride (TTC) staining for stroke
6 ed at 24 h after acute coronary occlusion by triphenyltetrazolium chloride (TTC) staining in wild-typ
7                                              Triphenyltetrazolium chloride (TTC) staining indicated t
8 e relationship of infarct size determined by triphenyltetrazolium chloride (TTC) staining versus (99m
9                                   Postmortem triphenyltetrazolium chloride (TTC) staining was used to
10           Cell death was visualized by 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxyli
11 wed by infarct volumes measurements by 2,3,5-triphenyltetrazolium chloride (TTC) staining.
12 maging, microsphere blood flow analysis, and triphenyltetrazolium chloride (TTC) staining.
13  24-h post-ischaemia by histology with 2,3,5-triphenyltetrazolium chloride (TTC) staining.
14                  Histochemical staining with triphenyltetrazolium chloride (TTC) was used to confirm
15                                              Triphenyltetrazolium chloride (TTC) was used to delineat
16  Heart slices were imaged, then stained with triphenyltetrazolium chloride (TTC), and tissues were we
17 d with microsphere-determined blood flow and triphenyltetrazolium chloride (TTC)-stained tissue sampl
18 into coronal slices and stained with 2, 3, 5-triphenyltetrazolium chloride (TTC).
19 )Na MRI correlated best with infarct size by triphenyltetrazolium chloride and contrast-enhanced (1)H
20 farct size, determined by dual staining with triphenyltetrazolium chloride and phthalocyanine blue dy
21 farct size, determined by dual staining with triphenyltetrazolium chloride and phthalocyanine blue dy
22 compared with normal remote regions, without triphenyltetrazolium chloride evidence of necrosis.
23  both models despite normal perfusion and no triphenyltetrazolium chloride evidence of necrosis.
24     The brains were removed and stained with triphenyltetrazolium chloride for infarct volume determi
25                                              Triphenyltetrazolium chloride infarcts among animals wit
26      Infarcted regions were defined as 2,3,5 triphenyltetrazolium chloride negative regions.
27 hin 24 h after reperfusion and compared with triphenyltetrazolium chloride pathology.
28       Assessment of necrosis by histology or triphenyltetrazolium chloride showed 40+/-5% multifocal
29 tion (IF) for each segment was determined by triphenyltetrazolium chloride stain.
30 8.5% +/- 0.9 vs 11.3% +/- 0.9, P = .048) and triphenyltetrazolium chloride staining (9.4% +/- 1.5 vs
31       MDCT infarct volume compared well with triphenyltetrazolium chloride staining (acute infarcts 2
32  with infarct volumes as determined by 2,3,5-triphenyltetrazolium chloride staining (R(2) = 0.692, P
33 red by in vivo 23Na MRI correlated well with triphenyltetrazolium chloride staining (r=0.87, y=0.92x+
34 -dependent brain damage as revealed by 2,3,5-triphenyltetrazolium chloride staining (severe > moderat
35                  In nonbeating hearts and at triphenyltetrazolium chloride staining at 1 week, microi
36 s assessed by serial echocardiography, 2,3,5-triphenyltetrazolium chloride staining determined infarc
37 echo time 8 ms, 2-tesla system), followed by triphenyltetrazolium chloride staining for infarct detec
38 ion in infarct volumes (P < 0.001), based on triphenyltetrazolium chloride staining of serial cerebra
39                             Postmortem 2,3,5-triphenyltetrazolium chloride staining quantified SEMI.
40                                              Triphenyltetrazolium chloride staining showed that infar
41 sessed by echocardiography couple with 2,3,5-Triphenyltetrazolium chloride staining to measure MI siz
42 was compared with pathological (exclusion of triphenyltetrazolium chloride staining) and ICE measurem
43 iated with a decreased infarct volume (2,3,5-triphenyltetrazolium chloride staining) in the striatum
44                                Infarct size (triphenyltetrazolium chloride staining) was comparable b
45                                         With triphenyltetrazolium chloride staining, anatomic infarct
46         Infarct size was determined by 2,3,5-triphenyltetrazolium chloride staining, and creatine kin
47 y, magnetic resonance imaging, hemodynamics, triphenyltetrazolium chloride staining, and histological
48            Infarct size (IS) was measured by triphenyltetrazolium chloride staining, and iNOS express
49 Myocardial infarct size was measured through triphenyltetrazolium chloride staining, and polymorphonu
50               Infarct size was determined by triphenyltetrazolium chloride staining, and the activity
51 tion of cerebral infarct volumes measured by triphenyltetrazolium chloride staining, as well as impro
52 imaging results were confirmed by postmortem triphenyltetrazolium chloride staining, elastica van Gie
53       Ischemic lesion was evaluated by 2,3,5-triphenyltetrazolium chloride staining, hematoxylin and
54 Infarcted, reperfused regions, identified by triphenyltetrazolium chloride staining, showed a signifi
55 -activated cell sorting and hearts for 2,3,5-triphenyltetrazolium chloride staining.
56 hibitor cucurbitacin I (JSI-124) using 2,3,5-triphenyltetrazolium chloride staining.
57 MA and Gd-DTPA and were confirmed by ex vivo triphenyltetrazolium chloride staining.
58 CAO, and infarct volume was determined using triphenyltetrazolium chloride staining.
59 erfusion, and infarct size was quantified by triphenyltetrazolium chloride staining.
60 ts were free of infarction, as detected with triphenyltetrazolium chloride staining.
61 s were defined by anti-myoglobin antibody or triphenyltetrazolium chloride staining.
62  fluorescent particles and infarct size with triphenyltetrazolium chloride staining.
63 extent of necrosis (TEN) (%) was measured by triphenyltetrazolium chloride staining.
64  extent of the infarct was assessed by 2,3,5 triphenyltetrazolium chloride staining.
65               Infarct size was determined by triphenyltetrazolium chloride staining.
66 measured at 22 hrs of reperfusion with 2,3,5-triphenyltetrazolium chloride staining.
67 nd infarct volume was assessed after 48 h by triphenyltetrazolium chloride staining.
68 (left ventricular pressure-volume curves; 1% triphenyltetrazolium chloride staining; creatine kinase
69         The infarction size defined by using triphenyltetrazolium chloride was 13% +/- 4 smaller than
70 ompared with postmortem myocardial staining (triphenyltetrazolium chloride) and microsphere blood flo
71                  The effect on infarct size (triphenyltetrazolium chloride) of acute ethanol exposure
72 ), less decline in +/-dP/dt, and smaller MI (triphenyltetrazolium chloride, 21+/-11% versus 3+/-8%; P
73 characterized by magnetic resonance imaging, triphenyltetrazolium chloride, and hemotoxylin and eosin
74 brains were sectioned and stained with 2,3,5-triphenyltetrazolium chloride, and the infarct area was
75 itially using the cell viability stain 2,3,5-triphenyltetrazolium chloride, but was determined in sub
76 obstruction (thioflavin S) and infarct size (triphenyltetrazolium chloride, TTC).
77 abnormal time constants correlated well with triphenyltetrazolium chloride-determined infarct size (r
78 ined by quantitative image analysis of 2,3,5-triphenyltetrazolium chloride-stained brain sections.
79 tion of the pattern of dye staining on 2,3,5-triphenyltetrazolium chloride-stained heart slices agree
80 ined by threshold analysis and compared with triphenyltetrazolium chloride-stained sections of the ex
81     Ablation size was visualized by using 2% triphenyltetrazolium chloride.
82  measurement of formazan produced from 2,3,5-triphenyltetrazolium chloride.
83 troxyl reduction was confirmed using EPR and triphenyltetrazolium chloride.
84 dium was stained with thioflavin-S and 2,3,5-triphenyltetrazolium chloride.
85  reperfusion, infarct size was measured with triphenyltetrazolium chloride.
86    Postmortem infarct size was measured with triphenyltetrazolium chloride.
87 ea infarcted was determined by staining with triphenyltetrazolium chloride.
88 ricle, 2.2+/-0.5% versus 5.4+/-1.5%, P=0.04; triphenyltetrazolium chloride: anterior wall, 10.3+/-4.6
89                                              Triphenyltetrazolium-determined injury volume of the ips
90 nt of the area at risk (AAR) was measured by triphenyltetrazolium stain.
91    Myocardial infarct size was determined by triphenyltetrazolium staining and expressed as a percent
92                                      We used triphenyltetrazolium staining to determine the amount of
93                                              Triphenyltetrazolium staining was used to assess the ext
94  of the area at risk (AAR) was determined by triphenyltetrazolium staining.
95 ffect of treatment being evaluated by 2,3, 5-triphenyltetrazolium (TTC) staining after 3 days of reco
96 , hemorrhages are adjacent to areas of 2,3,5-triphenyltetrazolium (TTC)-negative tissue, normally ass
97 ermined by staining slices of the heart with triphenyltetrazolium, was significantly reduced in PC co

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。